These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Malaysia and harm reduction: the challenges and responses. Reid G; Kamarulzaman A; Sran SK Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356 [TBL] [Abstract][Full Text] [Related]
23. Issues of social impact and response. Amsterdam report. Bryce J AIDS Soc; 1992; 3(4):5, 8. PubMed ID: 12317711 [TBL] [Abstract][Full Text] [Related]
24. Measuring attitudes toward injecting drug users and people with hepatitis C. Brener L; von Hippel W Subst Use Misuse; 2008; 43(3-4):295-302. PubMed ID: 18365932 [TBL] [Abstract][Full Text] [Related]
25. Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India. Hangzo C; Chatterjee A; Sarkar S; Zomi GT; Deb BC; Abdul-Quader AS Addiction; 1997 Jul; 92(7):813-20. PubMed ID: 9293040 [TBL] [Abstract][Full Text] [Related]
26. NIDA, HRSA join forces in studies of AIDS risk behavior by i.v. drug users. Delaney P Public Health Rep; 1990; 105(3):323. PubMed ID: 2113694 [No Abstract] [Full Text] [Related]
27. Double victims: poor women and AIDS. Shayne VT; Kaplan BJ Women Health; 1991; 17(1):21-37. PubMed ID: 2048320 [TBL] [Abstract][Full Text] [Related]
28. Obstacles to the development of prevention and public health policies in Argentina. Touzé G Clin Infect Dis; 2003 Dec; 37 Suppl 5():S372-5. PubMed ID: 14648450 [TBL] [Abstract][Full Text] [Related]
29. Harm reduction, HIV and development. Deany P; Crofts N Dev Bull; 2000 Jun; (52):45-8. PubMed ID: 12179450 [TBL] [Abstract][Full Text] [Related]
30. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions. Kalichman SC Psychosom Med; 2008 Jun; 70(5):593-7. PubMed ID: 18519882 [TBL] [Abstract][Full Text] [Related]
32. The change from intravenous to crack cocaine and its impact on reducing HIV incidence in Brazilian prisons. Burattini MN; Strazza L; Paoliello AA; de Carvalho HB; de Azevedo RS; Coutinho FA; Massad E Int J STD AIDS; 2005 Dec; 16(12):836-7. PubMed ID: 16336774 [No Abstract] [Full Text] [Related]
33. Drug use and HIV/AIDS in China. Liu Z; Lian Z; Zhao C Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308 [TBL] [Abstract][Full Text] [Related]
34. HIV risk behaviour among injecting drug users in Warsaw. Stark K; Sieroslawski J; Wirth D; Godwod-Sikorska C; Müller R; Bienzle U AIDS; 1995 Feb; 9(2):211-3. PubMed ID: 7718198 [No Abstract] [Full Text] [Related]
35. Risk contexts and risk behaviors in the Euregion Maas-Rhein: the Boule de Neige intervention for AIDS prevention among drug users. Franken IH; Kaplan CD AIDS Educ Prev; 1997 Apr; 9(2):161-80. PubMed ID: 9167801 [TBL] [Abstract][Full Text] [Related]
36. A personal network approach to AIDS prevention: an experimental peer group intervention for street-injecting drug users: the SAFE study. Latkin CA NIDA Res Monogr; 1995; 151():181-95. PubMed ID: 8742766 [No Abstract] [Full Text] [Related]
37. Community-based AIDS prevention interventions: special issues of women intravenous drug users. Mondanaro J NIDA Res Monogr; 1990; 93():68-82. PubMed ID: 2300149 [No Abstract] [Full Text] [Related]
38. HIV / STDs and drug use. Des Jarlais DC AIDS STD Health Promot Exch; 1997; (2):1-3. PubMed ID: 12292764 [TBL] [Abstract][Full Text] [Related]
39. Prevention of HIV/AIDS among injection drug users: the theory and science of public health and criminal justice approaches to disease prevention. Gostin LO; Lazzarini Z Emory Law J; 1997; 46(2):587-696. PubMed ID: 11769762 [No Abstract] [Full Text] [Related]
40. Failed drug policies in the United States and the future of AIDS: a perfect storm. Drucker E J Public Health Policy; 2012 Aug; 33(3):309-16. PubMed ID: 22895500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]